215 related articles for article (PubMed ID: 20959840)
1. The value of vaccines: our nation's front line against infectious diseases.
Gellin B; Landry S
Clin Pharmacol Ther; 2010 Nov; 88(5):580-1. PubMed ID: 20959840
[No Abstract] [Full Text] [Related]
2. Immunosenescence and herd immunity: with an ever-increasing aging population do we need to rethink vaccine schedules?
Lang PO; Aspinall R
Expert Rev Vaccines; 2012 Feb; 11(2):167-76. PubMed ID: 22309666
[TBL] [Abstract][Full Text] [Related]
3. Maintaining the vaccine safety net.
Hannan C; Buchanan AD; Monroe J
Pediatrics; 2009 Dec; 124 Suppl 5():S571-2. PubMed ID: 19948593
[No Abstract] [Full Text] [Related]
4. [Vaccination--value for money?].
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Kristiansen IS
Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2670-3. PubMed ID: 17057767
[TBL] [Abstract][Full Text] [Related]
5. Optimizing the acceptability, effectiveness and costs of immunization programs: the Quebec experience.
De Wals P
Expert Rev Vaccines; 2011 Jan; 10(1):55-62. PubMed ID: 21162621
[TBL] [Abstract][Full Text] [Related]
6. Assessing the impact of wastage on pediatric vaccine immunization formulary costs using a vaccine selection algorithm.
Jacobson SH; Karnani T; Sewell EC
Vaccine; 2004 Jun; 22(17-18):2307-15. PubMed ID: 15149790
[TBL] [Abstract][Full Text] [Related]
7. Methodological issues and new developments in the economic evaluation of vaccines.
Beutels P; Van Doorslaer E; Van Damme P; Hall J
Expert Rev Vaccines; 2003 Oct; 2(5):649-60. PubMed ID: 14711326
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
[TBL] [Abstract][Full Text] [Related]
9. Immunosenescence: Implications for vaccination programmes in adults.
Lang PO; Govind S; Michel JP; Aspinall R; Mitchell WA
Maturitas; 2011 Apr; 68(4):322-30. PubMed ID: 21316879
[TBL] [Abstract][Full Text] [Related]
10. Vaccines as community-focused therapy.
May T
Expert Rev Vaccines; 2003 Jun; 2(3):341-3. PubMed ID: 12903800
[No Abstract] [Full Text] [Related]
11. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
[TBL] [Abstract][Full Text] [Related]
12. The European effort towards the development of mucosal vaccines for poverty-related diseases.
Medaglini D; Olesen OF; Rappuoli R
Vaccine; 2009 May; 27(20):2641-8. PubMed ID: 19428873
[TBL] [Abstract][Full Text] [Related]
13. Oral vaccines: new needs, new possibilities.
Aziz MA; Midha S; Waheed SM; Bhatnagar R
Bioessays; 2007 Jun; 29(6):591-604. PubMed ID: 17508389
[TBL] [Abstract][Full Text] [Related]
14. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
Armstrong GL; Billah K; Rein DB; Hicks KA; Wirth KE; Bell BP
Pediatrics; 2007 Jan; 119(1):e22-9. PubMed ID: 17200247
[TBL] [Abstract][Full Text] [Related]
15. Weapons of mass protection.
Nat Med; 2003 Mar; 9(3):239. PubMed ID: 12612548
[No Abstract] [Full Text] [Related]
16. [Vaccines for all occasions].
Passwell JH
Harefuah; 2004 Aug; 143(8):576-7, 622. PubMed ID: 15523809
[TBL] [Abstract][Full Text] [Related]
17. The role of surveillance in assuring mutual protection for vaccine-preventable diseases.
Lopalco PL
Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S85-S88. PubMed ID: 27476865
[TBL] [Abstract][Full Text] [Related]
18. Take your best shot at prevention by staying up to date on recommended vaccines.
Schaffner W
Diabetes Self Manag; 2014 Oct; 31(5):62-3. PubMed ID: 25322658
[No Abstract] [Full Text] [Related]
19. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
Isaacman DJ; Strutton DR; Kalpas EA; Horowicz-Mehler N; Stern LS; Casciano R; Ciuryla V
Clin Ther; 2008 Feb; 30(2):341-57. PubMed ID: 18343273
[TBL] [Abstract][Full Text] [Related]
20. Response to "Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences".
Proano RA; Jacobson SH; Jokela JA
Vaccine; 2011 Jan; 29(4):615; author reply 616. PubMed ID: 21094271
[No Abstract] [Full Text] [Related]
[Next] [New Search]
